Revance Reports First Quarter 2020 Financial Results, Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
Revance Therapeutics (RVNC) Misses Q1 EPS by 25c
May 7, 2020 5:30 PM EDTRevance Therapeutics (NASDAQ: RVNC) reported Q1 EPS of ($1.15), $0.25 worse than the analyst estimate of ($0.90).
First of all, I would like to sincerely thank all of those who are currently... More
